Nivalis Therapeutics, Inc. (NVLS)

Sorry, no known transcripts

Recent filings

Nivalis Therapeutics, Inc. Just Filed Its Quarterly Report: 4. Net Income (Loss... - Nov. 14, 2017

Nivalis Therapeutics: Alpine Immune Sciences And Kite Extend Research Term - Oct. 24, 2017

Nivalis Therapeutics: Alpine Immune Sciences, Inc CONDENSED BALANCE SHEETS - Sept. 29, 2017

Securities to be offered to employees in employee benefit plans, post-effective amendments - Sept. 11, 2017

General statement of acquisition of beneficial ownership - Aug. 22, 2017

Jay Venkatesan just provided an update on activist position in Nivalis Therapeutics, Inc. - Aug. 3, 2017

Samuel D. Isaly just provided an update on activist position in Nivalis Therapeutics, Inc. - Aug. 3, 2017

Patrick J. Heron just provided an update on activist position in Nivalis Therapeutics, Inc. - July 31, 2017

Major owner of Nivalis Therapeutics, Inc. just declared owning 2,199,011 shares of Nivalis Therapeutics, Inc. - July 28, 2017

General statement of acquisition of beneficial ownership - July 28, 2017

Mark N. Lampert just provided an update on share ownership of Nivalis Therapeutics, Inc. - July 27, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 3,298,516 shares - July 26, 2017

Nivalis Therapeutics, Inc.'s See Remarks was just granted 198,759 options - July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 3,901,733 shares - July 26, 2017

Nivalis Therapeutics, Inc.'s Senior VP and CFO was just granted 74,535 options - July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 2,199,011 shares - July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 3,298,516 shares - July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 3,862,911 shares - July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just declared owning 3,803,906 shares of Nivalis Therapeutics, Inc. - July 26, 2017

Nivalis Therapeutics, Inc.'s Executive Chairman and CEO just declared ownership of no shares of Nivalis Therapeutics, Inc. - July 26, 2017

Nivalis Therapeutics, Inc.'s President just declared ownership of no shares of Nivalis Therapeutics, Inc. - July 26, 2017

Nivalis Therapeutics, Inc.'s See Remarks just declared ownership of no shares of Nivalis Therapeutics, Inc. - July 26, 2017

Nivalis Therapeutics, Inc. director just declared ownership of no shares of Nivalis Therapeutics, Inc. - July 26, 2017

Nivalis Therapeutics, Inc. director just declared ownership of no shares of Nivalis Therapeutics, Inc. - July 26, 2017

Nivalis Therapeutics, Inc. director just declared ownership of no shares of Nivalis Therapeutics, Inc. - July 26, 2017

Nivalis Therapeutics, Inc.'s Senior VP and CFO just declared ownership of no shares of Nivalis Therapeutics, Inc. - July 26, 2017

Alpine Immune Sciences, Inc. Completes Merger With Nivalis Therapeutics, Inc - July 25, 2017

Nivalis Therapeutics, Inc. Just Filed Its Quarterly Report: Net Loss per Shar... - July 21, 2017

Nivalis Therapeutics: Separation Agreement And General Release - July 20, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 17,806 shares - June 22, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 72,650 shares - June 7, 2017

Nivalis Therapeutics, Inc. Just Received a Notice of Effectiveness - June 6, 2017

Nivalis Therapeutics, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - June 6, 2017

Nivalis Therapeutics, Inc. Sets Date For Special Meeting Of Stockholders - June 2, 2017

Prospectuses and communications, business combinations - June 2, 2017

Registration of securities, business combinations - June 2, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 47,000 shares - June 1, 2017

Registration of securities, business combinations - May 19, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 78,858 shares - May 19, 2017

SUBMISSION OF MATTERS TO A VOTE OF SECURITY - May 17, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 109,034 shares - May 11, 2017

Major owner of Nivalis Therapeutics, Inc. just declared owning 1,702,810 shares of Nivalis Therapeutics, Inc. - May 11, 2017

Nivalis Therapeutics, Inc. director just picked up 15,000 shares - May 11, 2017

Nivalis Therapeutics, Inc. director just picked up 5,000 shares - May 10, 2017

Nivalis Therapeutics, Inc.'s Exec Vice President / COO just picked up 10,000 shares - May 9, 2017

Nivalis Therapeutics, Inc. director just picked up 20,000 shares - May 9, 2017

Nivalis Therapeutics, Inc. director just picked up 10,000 shares - May 8, 2017

Nivalis Therapeutics, Inc. Just Filed Its Quarterly Report: Net Loss per Shar... - May 2, 2017

Nivalis Therapeutics Reports First Quarter 2017 Financial Results - May 1, 2017

Prospectuses and communications, business combinations - April 28, 2017

Nivalis Therapeutics: Introduction To Alpine Immune Sciences April 28, 2017 - April 28, 2017

General statement of acquisition of beneficial ownership - April 25, 2017

Prospectuses and communications, business combinations - April 19, 2017

Nivalis Therapeutics, Inc. And Alpine Immune Sciences, Inc. Agree To Combine - April 18, 2017

Prospectuses and communications, business combinations - April 18, 2017

Nivalis Therapeutics, Inc. releases salary data. CEO sees compensation fall -39% - April 6, 2017

Mark N. Lampert just provided an update on share ownership of Nivalis Therapeutics, Inc. - Feb. 14, 2017

Nivalis Therapeutics Reports Fourth Quarter And Full-Year 2016 Financial Results - Feb. 13, 2017

Wellington Management Group LLP just issued a filing suggesting it has sold all of its Nivalis Therapeutics, Inc. - Feb. 10, 2017

Wellington Management Company LLP just provided an update on share ownership of Nivalis Therapeutics, Inc. - Feb. 9, 2017

Nivalis Therapeutics, Inc.'s Interim President / CFO was just granted 200,000 options - Jan. 23, 2017

Nivalis Therapeutics, Inc.'s Exec Vice President / COO was just granted 200,000 options - Jan. 23, 2017

Nivalis Therapeutics Announces Corporate Restructuring - Jan. 12, 2017

Nivalis Therapeutics, Inc.'s Exec Vice President and CMO just picked up 11,368 shares - Jan. 5, 2017

Nivalis Therapeutics Announces Review Of Strategic Alternatives BOULDER, Colo., - Jan. 4, 2017

Nivalis Therapeutics, Inc.'s Exec Vice President / CFO just picked up 24,000 shares - Dec. 5, 2016

Nivalis Therapeutics Announces Results From Phase 2 Clinical Trial Of Cavosonstat For Treatment Of Cystic Fibrosis - Nov. 28, 2016

Nivalis Therapeutics, Inc. Just Filed Its Quarterly Report: Net Loss per Shar... - Nov. 7, 2016

Nivalis Therapeutics Reports Third Quarter 2016 Financial Results - Nov. 7, 2016

Nivalis Therapeutics Announces Appointment Of Cynthia Smith To - Nov. 3, 2016

Nivalis Therapeutics, Inc.'s Exec Vice President and CMO just picked up 12,236 shares - Oct. 5, 2016

James E. Flynn just provided an update on activist position in Nivalis Therapeutics, Inc. - Sept. 20, 2016

Major owner of Nivalis Therapeutics, Inc. was just granted 12,300 options - Sept. 14, 2016

Nivalis Therapeutics, Inc. director was just granted 12,300 options - Sept. 14, 2016

Nivalis Therapeutics, Inc.'s President and CEO was just granted 250,000 options - Sept. 14, 2016

Nivalis Therapeutics, Inc.'s Exec Vice President / CFO was just granted 110,000 options - Sept. 14, 2016

Nivalis Therapeutics, Inc. director was just granted 12,300 options - Sept. 14, 2016

Nivalis Therapeutics, Inc. director was just granted 12,300 options - Sept. 14, 2016

Nivalis Therapeutics, Inc.'s Exec Vice President / COO was just granted 110,000 options - Sept. 14, 2016

Nivalis Therapeutics, Inc. director was just granted 12,300 options - Sept. 14, 2016

Nivalis Therapeutics, Inc.'s Exec Vice President and CMO was just granted 100,000 options - Sept. 14, 2016

Nivalis Therapeutics, Inc. director was just granted 12,300 options - Sept. 14, 2016

Nivalis Therapeutics, Inc. Just Filed Its Quarterly Report: Net Loss per Shar... - Aug. 2, 2016

Nivalis Therapeutics Reports Second Quarter 2016 Financial Results - Aug. 1, 2016

Nivalis Therapeutics, Inc. Just Received a Notice of Effectiveness - July 14, 2016

Nivalis Therapeutics: Ivalis Therapeutics Announces Completion Of Enrollment In Phase 2 Study - July 7, 2016

Nivalis Therapeutics, Inc.'s Exec Vice President and CMO just picked up 12,105 shares - July 6, 2016

Registration statement under Securities Act of 1933 - July 6, 2016

Nivalis Therapeutics, Inc.'s President and CEO just picked up 5,000 shares - June 17, 2016

Nivalis Therapeutics Announces First Patient Dosed In Second Phase 2 Study - May 16, 2016

Securities to be offered to employees in employee benefit plans - May 6, 2016

Nivalis Therapeutics, Inc. Just Filed Its Quarterly Report: Net Loss per Shar... - May 3, 2016

Nivalis Therapeutics Reports First Quarter 2016 Financial Results - May 2, 2016

SUBMISSION OF MATTERS TO A VOTE OF SECURITY - May 2, 2016

Nivalis Therapeutics, Inc.'s See Remarks just declared 216,667 options and restricted shares - April 22, 2016

Nivalis Therapeutics Appoints David Rodman, Md As Chief Medical Officer And Executive Vice President Of Discovery - April 22, 2016

Nivalis Therapeutics Reaches 50 Percent Enrollment Milestone In Phase 2 - April 5, 2016

Nivalis Therapeutics, Inc.'s President and CEO just picked up 5,000 shares - March 25, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. WALL STREET ASSOCIATES 170,400 0.5 Sept. 30, 2016
2. BlackRock Institutional Trust Company, N.A. 56,859 N/A Dec. 31, 2016
3. NORTHERN TRUST CORP 30,449 N/A June 30, 2017
4. BlackRock Fund Advisors 24,880 N/A Sept. 30, 2016
5. MetLife Securities, Inc 20,000 N/A Dec. 31, 2016
6. KCG Holdings, Inc. 12,094 N/A June 30, 2017
7. MORGAN STANLEY 4,397 N/A Dec. 31, 2016
8. BlackRock Investment Management, LLC 1,775 N/A Dec. 31, 2016
9. BlackRock Advisors LLC 1,611 N/A Sept. 30, 2016
10. BlackRock Japan Co. Ltd 1,606 N/A Sept. 30, 2016

Nivalis Therapeutics, Inc. (NVLS)

140

cctranscripts

Nov. 14, 2017

Nivalis Therapeutics, Inc. Just Filed Its Quarterly Report: 4. Net Income (Loss... http://www.conferencecalltranscripts.org/pink/summary?id=4321720

cctranscripts

Oct. 24, 2017

Nivalis Therapeutics: Alpine Immune Sciences And Kite Extend Research Term http://www.conferencecalltranscripts.org/pink/summary?id=4246771

cctranscripts

Sept. 29, 2017

Nivalis Therapeutics: Alpine Immune Sciences, Inc CONDENSED BALANCE SHEETS http://www.conferencecalltranscripts.org/pink/summary?id=4186948

cctranscripts

Sept. 11, 2017

Securities to be offered to employees in employee benefit plans, post-effective amendments http://www.conferencecalltranscripts.org/pink/summary?id=4134654

cctranscripts

Aug. 22, 2017

General statement of acquisition of beneficial ownership http://www.conferencecalltranscripts.org/pink/summary?id=4078394

cctranscripts

Aug. 3, 2017

Samuel D. Isaly just provided an update on activist position in Nivalis Therapeutics, Inc. http://www.conferencecalltranscripts.org/pink/summary?id=4018538

cctranscripts

Aug. 3, 2017

Jay Venkatesan just provided an update on activist position in Nivalis Therapeutics, Inc. http://www.conferencecalltranscripts.org/pink/summary?id=4019362

cctranscripts

July 31, 2017

Patrick J. Heron just provided an update on activist position in Nivalis Therapeutics, Inc. http://www.conferencecalltranscripts.org/pink/summary?id=4002536

cctranscripts

July 28, 2017

General statement of acquisition of beneficial ownership http://www.conferencecalltranscripts.org/pink/summary?id=3999296

cctranscripts

July 28, 2017

Major owner of Nivalis Therapeutics, Inc. just declared owning 2,199,011 shares of Nivalis Therapeutics, Inc. http://www.conferencecalltranscripts.org/pink/summary?id=3999621

cctranscripts

July 27, 2017

Mark N. Lampert just provided an update on share ownership of Nivalis Therapeutics, Inc. http://www.conferencecalltranscripts.org/pink/summary?id=3995489

cctranscripts

July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 3,901,733 shares http://www.conferencecalltranscripts.org/pink/summary?id=3990668

cctranscripts

July 26, 2017

Nivalis Therapeutics, Inc.'s See Remarks was just granted 198,759 options http://www.conferencecalltranscripts.org/pink/summary?id=3990672

cctranscripts

July 26, 2017

Nivalis Therapeutics, Inc.'s Senior VP and CFO was just granted 74,535 options http://www.conferencecalltranscripts.org/pink/summary?id=3990665

cctranscripts

July 26, 2017

Nivalis Therapeutics, Inc.'s Executive Chairman and CEO just declared ownership of no shares of Nivalis Therapeutics, Inc. http://www.conferencecalltranscripts.org/pink/summary?id=3990611

cctranscripts

July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just declared owning 3,803,906 shares of Nivalis Therapeutics, Inc. http://www.conferencecalltranscripts.org/pink/summary?id=3990613

cctranscripts

July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 3,862,911 shares http://www.conferencecalltranscripts.org/pink/summary?id=3990656

cctranscripts

July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 3,298,516 shares http://www.conferencecalltranscripts.org/pink/summary?id=3990659

cctranscripts

July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 2,199,011 shares http://www.conferencecalltranscripts.org/pink/summary?id=3990664

cctranscripts

July 26, 2017

Major owner of Nivalis Therapeutics, Inc. just picked up 3,298,516 shares http://www.conferencecalltranscripts.org/pink/summary?id=3990702
 


Feedback